Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Dec;26(3):933–941. doi: 10.1128/iai.26.3.933-941.1979

Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis.

W P Kaschka, L Theilkaes, K Eickhoff, F Skvaril
PMCID: PMC414709  PMID: 528058

Abstract

We determined immunoglobulin G (IgG) subclass concentrations and studied their distributions in the cerebrospinal fluids of patients suffering from multiple sclerosis, other inflammatory neurological diseases, and non-inflammatory diseases of the nervous system in comparison with a control group. In addition, the four subclass concentrations were measured in serum specimens of the multiple sclerosis and control groups. These data were correlated with the extent of local IgG synthesis in the subarachnoid spaces of the patients belonging to the different groups. We found a selective elevation of the IgG1 subclass in the cerebrospinal fluids of multiple sclerosis patients, and there was only a very small overlap of the IgG1 ranges of the multiple sclerosis and control groups. No major differences were detected between the IgG subclass distributions in different courses of multiple sclerosis nor between multiple sclerosis and control sera. The group with non-inflammatory diseases showed a uniform elevation of all four subclasses and a greater overlap with the normal range. This latter feature was combined with an elevated IgG1 concentration in the group with other inflammatory diseases. It is concluded that locally synthesized IgG in the cerebrospinal fluids of multiple sclerosis patients consists mainly of IgG1.

Full text

PDF
936

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bollengier F., Delmotte P., Lowenthal A. Biochemical findings in multiple sclerosis. III. Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis. J Neurol. 1976 Apr 23;212(2):151–158. doi: 10.1007/BF00329158. [DOI] [PubMed] [Google Scholar]
  2. Bollengier F., Lowenthal A., Henrotin W. Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis serum and cerebrospinal fluid. Z Klin Chem Klin Biochem. 1975 Jul;13(7):305–310. doi: 10.1515/cclm.1975.13.7.305. [DOI] [PubMed] [Google Scholar]
  3. Delpech B., Lichtblau E. Etude quantitative des immunoglobulines G et de l'albumine du liquide cephalo rachidien. Clin Chim Acta. 1972 Mar;37:15–23. doi: 10.1016/0009-8981(72)90410-x. [DOI] [PubMed] [Google Scholar]
  4. Ebers G. C., Zabriskie J. B., Kunkel H. G. Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants. Clin Exp Immunol. 1979 Jan;35(1):67–75. [PMC free article] [PubMed] [Google Scholar]
  5. Eickhoff K., Heipertz R. Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction. Acta Neurol Scand. 1977 Dec;56(6):475–482. doi: 10.1111/j.1600-0404.1977.tb01454.x. [DOI] [PubMed] [Google Scholar]
  6. FRICK E., SCHEID-SEYDEL L. Untersuchungen mit J 131-markiertem gamma-Globulin zur Frage der Abstammung der Liquoreiweisskörper. Klin Wochenschr. 1958 Sep 15;36(18):857–863. doi: 10.1007/BF01485232. [DOI] [PubMed] [Google Scholar]
  7. Fujinami R. S., Oldstone M. B. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature. 1979 Jun 7;279(5713):529–530. doi: 10.1038/279529a0. [DOI] [PubMed] [Google Scholar]
  8. Ganrot K., Laurell C. B. Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem. 1974 May;20(5):571–573. [PubMed] [Google Scholar]
  9. Kjellin K. G., Siden A. Aberrant CSF protein fractions found by electrofocusing in multiple sclerosis. A study of 26 cases with clinically verified or probable multiple sclerosis and 2 cases with optic neuritis. Eur Neurol. 1977;15(1):40–50. doi: 10.1159/000114787. [DOI] [PubMed] [Google Scholar]
  10. Kvist S., Ostberg L., Persson H., Philipson L., Peterson P. A. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5674–5678. doi: 10.1073/pnas.75.11.5674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Link H., Zettervall O. Multiple sclerosis: disturbed kappa: lambda chain ratio of immunoglobulin G in cerebrospinal fluid. Clin Exp Immunol. 1970 Mar;6(3):435–438. [PMC free article] [PubMed] [Google Scholar]
  12. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  13. Roberts-Thomson P. J., Esiri M. M., Young A. C., Maclennan I. C. Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease. J Clin Pathol. 1976 Dec;29(12):1105–1115. doi: 10.1136/jcp.29.12.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SCHUMACHER G. A., BEEBE G., KIBLER R. F., KURLAND L. T., KURTZKE J. F., MCDOWELL F., NAGLER B., SIBLEY W. A., TOURTELLOTTE W. W., WILLMON T. L. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
  15. Sandberg-Wollheim M., Zettervall O., Müller R. In vitro synthesis of IgG by cells from the cerebrospinal fluid in a patient with multiple sclerosis. Clin Exp Immunol. 1969 Apr;4(4):401–405. [PMC free article] [PubMed] [Google Scholar]
  16. Shakib F., Stanworth D. R., Drew R., Catty D. A quantitative study of the distribution of IgG sub-classes in a group of normal human sera. J Immunol Methods. 1975;8(1-2):17–28. doi: 10.1016/0022-1759(75)90077-0. [DOI] [PubMed] [Google Scholar]
  17. Tourtellotte W. On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci. 1970 Mar;10(3):279–304. doi: 10.1016/0022-510x(70)90156-5. [DOI] [PubMed] [Google Scholar]
  18. Vandvik B., Degré M. Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system. J Neurol Sci. 1975 Feb;24(2):201–219. doi: 10.1016/0022-510x(75)90233-6. [DOI] [PubMed] [Google Scholar]
  19. Vandvik B., Natvig J. B., Wiger D. IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol. 1976;5(4):427–436. doi: 10.1111/j.1365-3083.1976.tb00297.x. [DOI] [PubMed] [Google Scholar]
  20. Vandvik B., Norrby E., Nordal H. J., Degré M. Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol. 1976;5(8):979–992. doi: 10.1111/j.1365-3083.1976.tb03050.x. [DOI] [PubMed] [Google Scholar]
  21. van der Giessen M., Rossouw E., van Veen T. A., van Loghem E., Zegers B. J., Sander P. C. Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Immunol. 1975 Sep;21(3):501–509. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES